Arkolith/Insider Trading/BBIO/Form 4

Cook Jennifer E.

DirectorBridgeBio Pharma, Inc. (BBIO) · full profile →Form 4 · filed Jul 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13.2M
Net Open-Market Flow
-$13.2M
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)19K$8.45$161K27K
Jul 9, 2026Option exercise(M)112K$29.00$3.3M140K
Jul 9, 2026Option exercise(M)17K$16.75$288K157K
Jul 9, 2026Sell(S)36K$84.00$3.0M121K
Jul 9, 2026Sell(S)112K$90.00$10.1M8K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)19K—$00
Jul 9, 2026Option exercise(M)112K—$00
Jul 9, 2026Option exercise(M)17K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001470831-26-000708) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML